TABLE 6D - INVALID PROCEDURE CODES
Procedure Code	Description	O.R.	MDC	MS-DRG
30230AZ*	Transfusion of Embryonic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	016, 017
30230C0*	Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Open Approach	N**	PRE	016, 017
30230G0*	Transfusion of Autologous Bone Marrow into Peripheral Vein, Open Approach	N**	PRE	016, 017
30230G2*	Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Open Approach	N**	PRE	014
30230G3*	Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Open Approach	N**	PRE	014
30230G4*	Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Open Approach	N**	PRE	014
30230H0*	Transfusion of Autologous Whole Blood into Peripheral Vein, Open Approach	N		
30230H1*	Transfusion of Nonautologous Whole Blood into Peripheral Vein, Open Approach	N		
30230J0*	Transfusion of Autologous Serum Albumin into Peripheral Vein, Open Approach	N		
30230J1*	Transfusion of Nonautologous Serum Albumin into Peripheral Vein, Open Approach	N		
30230K0*	Transfusion of Autologous Frozen Plasma into Peripheral Vein, Open Approach	N		
30230K1*	Transfusion of Nonautologous Frozen Plasma into Peripheral Vein, Open Approach	N		
30230L0*	Transfusion of Autologous Fresh Plasma into Peripheral Vein, Open Approach	N		
30230L1*	Transfusion of Nonautologous Fresh Plasma into Peripheral Vein, Open Approach	N		
30230M0*	Transfusion of Autologous Plasma Cryoprecipitate into Peripheral Vein, Open Approach	N		
30230M1*	Transfusion of Nonautologous Plasma Cryoprecipitate into Peripheral Vein, Open Approach	N		
30230N0*	Transfusion of Autologous Red Blood Cells into Peripheral Vein, Open Approach	N		
30230N1*	Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Open Approach	N		
30230P0*	Transfusion of Autologous Frozen Red Cells into Peripheral Vein, Open Approach	N		
30230P1*	Transfusion of Nonautologous Frozen Red Cells into Peripheral Vein, Open Approach	N		
30230Q0*	Transfusion of Autologous White Cells into Peripheral Vein, Open Approach	N		
30230Q1*	Transfusion of Nonautologous White Cells into Peripheral Vein, Open Approach	N		
30230R0*	Transfusion of Autologous Platelets into Peripheral Vein, Open Approach	N		
30230R1*	Transfusion of Nonautologous Platelets into Peripheral Vein, Open Approach	N		
30230S0*	Transfusion of Autologous Globulin into Peripheral Vein, Open Approach	N		
30230S1*	Transfusion of Nonautologous Globulin into Peripheral Vein, Open Approach	N		
30230T0*	Transfusion of Autologous Fibrinogen into Peripheral Vein, Open Approach	N		
30230T1*	Transfusion of Nonautologous Fibrinogen into Peripheral Vein, Open Approach	N		
30230U2*	Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230U3*	Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230U4*	Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230V0*	Transfusion of Autologous Antihemophilic Factors into Peripheral Vein, Open Approach	N		
30230V1*	Transfusion of Nonautologous Antihemophilic Factors into Peripheral Vein, Open Approach	N		
30230W0*	Transfusion of Autologous Factor IX into Peripheral Vein, Open Approach	N		
30230W1*	Transfusion of Nonautologous Factor IX into Peripheral Vein, Open Approach	N		
30230X0*	Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Open Approach	N**	PRE	016, 017
30230X2*	Transfusion of Allogeneic Related Cord Blood Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230X3*	Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230X4*	Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230Y0*	Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	016, 017
30230Y2*	Transfusion of Allogeneic Related Hematopoietic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230Y3*	Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30230Y4*	Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Peripheral Vein, Open Approach	N**	PRE	014
30240AZ*	Transfusion of Embryonic Stem Cells into Central Vein, Open Approach	N**	PRE	016, 017
30240C0*	Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Open Approach	N**	PRE	016, 017
30240G0*	Transfusion of Autologous Bone Marrow into Central Vein, Open Approach	N**	PRE	016, 017
30240G2*	Transfusion of Allogeneic Related Bone Marrow into Central Vein, Open Approach	N**	PRE	014
30240G3*	Transfusion of Allogeneic Unrelated Bone Marrow into Central Vein, Open Approach	N**	PRE	014
30240G4*	Transfusion of Allogeneic Unspecified Bone Marrow into Central Vein, Open Approach	N**	PRE	014
30240H0*	Transfusion of Autologous Whole Blood into Central Vein, Open Approach	N		
30240H1*	Transfusion of Nonautologous Whole Blood into Central Vein, Open Approach	N		
30240J0*	Transfusion of Autologous Serum Albumin into Central Vein, Open Approach	N		
30240J1*	Transfusion of Nonautologous Serum Albumin into Central Vein, Open Approach	N		
30240K0*	Transfusion of Autologous Frozen Plasma into Central Vein, Open Approach	N		
30240K1*	Transfusion of Nonautologous Frozen Plasma into Central Vein, Open Approach	N		
30240L0*	Transfusion of Autologous Fresh Plasma into Central Vein, Open Approach	N		
30240L1*	Transfusion of Nonautologous Fresh Plasma into Central Vein, Open Approach	N		
30240M0*	Transfusion of Autologous Plasma Cryoprecipitate into Central Vein, Open Approach	N		
30240M1*	Transfusion of Nonautologous Plasma Cryoprecipitate into Central Vein, Open Approach	N		
30240N0*	Transfusion of Autologous Red Blood Cells into Central Vein, Open Approach	N		
30240N1*	Transfusion of Nonautologous Red Blood Cells into Central Vein, Open Approach	N		
30240P0*	Transfusion of Autologous Frozen Red Cells into Central Vein, Open Approach	N		
30240P1*	Transfusion of Nonautologous Frozen Red Cells into Central Vein, Open Approach	N		
30240Q0*	Transfusion of Autologous White Cells into Central Vein, Open Approach	N		
30240Q1*	Transfusion of Nonautologous White Cells into Central Vein, Open Approach	N		
30240R0*	Transfusion of Autologous Platelets into Central Vein, Open Approach	N		
30240R1*	Transfusion of Nonautologous Platelets into Central Vein, Open Approach	N		
30240S0*	Transfusion of Autologous Globulin into Central Vein, Open Approach	N		
30240S1*	Transfusion of Nonautologous Globulin into Central Vein, Open Approach	N		
30240T0*	Transfusion of Autologous Fibrinogen into Central Vein, Open Approach	N		
30240T1*	Transfusion of Nonautologous Fibrinogen into Central Vein, Open Approach	N		
30240U2*	Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240U3*	Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240U4*	Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240V0*	Transfusion of Autologous Antihemophilic Factors into Central Vein, Open Approach	N		
30240V1*	Transfusion of Nonautologous Antihemophilic Factors into Central Vein, Open Approach	N		
30240W0*	Transfusion of Autologous Factor IX into Central Vein, Open Approach	N		
30240W1*	Transfusion of Nonautologous Factor IX into Central Vein, Open Approach	N		
30240X0*	Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Open Approach	N**	PRE	016, 017
30240X2*	Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240X3*	Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240X4*	Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240Y0*	Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Open Approach	N**	PRE	016, 017
30240Y2*	Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240Y3*	Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Open Approach	N**	PRE	014
30240Y4*	Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Open Approach	N**	PRE	014
30280B1*	Transfusion of Nonautologous 4-Factor Prothrombin Complex Concentrate into Vein, Open Approach	N		
X2C0361*	Extirpation of Matter from Coronary Artery, One Artery using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1	Y	05	231, 232, 246, 247, 248, 249, 250, 251
""				981, 982, 983
X2C1361*	Extirpation of Matter from Coronary Artery, Two Arteries using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1	Y	05	231, 232, 246, 247, 248, 249, 250, 251
""				981, 982, 983
X2C2361*	Extirpation of Matter from Coronary Artery, Three Arteries using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1	Y	05	231, 232, 246, 247, 248, 249, 250, 251
""				981, 982, 983
X2C3361*	Extirpation of Matter from Coronary Artery, Four or More Arteries using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1	Y	05	231, 232, 246, 247, 248, 249, 250, 251
""				981, 982, 983
XR2G021*	Monitoring of Right Knee Joint using Intraoperative Knee Replacement Sensor, Open Approach, New Technology Group 1	Y	08	485, 486, 487, 488, 489
""				987, 988, 989
XR2H021*	Monitoring of Left Knee Joint using Intraoperative Knee Replacement Sensor, Open Approach, New Technology Group 1	Y	08	485, 486, 487, 488, 489
""				987, 988, 989
XW03321*	Introduction of Ceftazidime-Avibactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 1	N		
XW03331*	Introduction of Idarucizumab, Dabigatran Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 1	N		
XW03341*	Introduction of Isavuconazole Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 1	N		
XW03351*	Introduction of Blinatumomab Antineoplastic Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 1	N		
XW033C3	Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 3	N**		018
XW04321*	Introduction of Ceftazidime-Avibactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 1	N		
XW04331*	Introduction of Idarucizumab, Dabigatran Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 1	N		
XW04341*	Introduction of Isavuconazole Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 1	N		
XW04351*	Introduction of Blinatumomab Antineoplastic Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 1	N		
XW043C3	Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 3	N**		018
XW23346	Transfusion of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6	N**		018
XW23376	Transfusion of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6	N**		018
XW24346	Transfusion of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6	N**		018
XW24376	Transfusion of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6	N**		018

	Notes:
	(*)-These codes were discussed at the March 9, 2021 - March 10, 2021 ICD-10 Coordination and Maintenance Committee meeting and were not finalized in time to include in the proposed rule. They will be implemented on October 1, 2021.
	(**)-Non-OR procedure affects DRGs
